(1)
Comparative Pharmacoeconomic Assessment of Apixaban Vs. Standard of Care for the Prevention of Stroke in Italian Atrial Fibrillation Patients. FE 2014, 15 (1S), 15-26. https://doi.org/10.7175/fe.v15i1s.974.